Search  in | Advanced
   Print  

Plenary Session Highlights Six Scientific Abstracts
By Jay Pennington

Among the 989 scientific oral and poster abstracts accepted for presentation in Montréal, six were selected for presentation at the plenary session. Plan to hear these outstanding presentations on Sunday from 8:30 to 10:00 am in Room 516C.

  • Human Neutrophil Antigen Antibody Prevalence in US Blood Donors. The results that will be presented are part of the NIH Retrovirus Epidemiology Donor Study, which evaluated the prevalence of HLA antibodies. The presentation will comment on the potential value for neutrophil antibody screening in addition to HLA antibody screening of donors with a pregnancy history.
  • Red Blood Cell Transfusion to a Hemoglobin of 10 g/dL Does Not Improve Survival in Non-Cardiac, Elective Surgical Patients: An Analysis of 117,418 Patients. A retrospective analysis of Haemonetics data involving patients from 20 hospitals from 2002 to 2007 was used to evaluate whether the common practice of providing allogeneic transfusion to raise hemoglobin levels to 10 g/dL effectively reduces mortality.
  • Duration and Recency of Risk Exposure in Male Blood Donors Deferred for Sex with Another Man. This study focused on male donors who were deferred for having had sex with another man since 1977 (MSMs) but whose MSM exposure was more than 1 year ago. The study evaluated the potential effect on the donor pool of accepting this subgroup as donors.
  • Selection, Expansion, and Functional Restoration of NS3-Specific CD4 T Cells from HCV-Infected Patients. In this study, hepatitis C virus (HCV)-specific CD4 T cells were isolated from five patients with persistent infection and five patients with spontaneous resolved infection. Functional restoration of interferon-g production was evaluated after ex-vivo expansion with homeostatic interleukins in the absence of the antigenic stimulus.
  • Trypanosoma cruzi Antibody Screening in US Blood Donors: One Year Experience at the American Red Cross. The authors will report results of testing for the parasite that causes Chagas’ disease, by enzyme-linked immunosorbent assay and radioimmunoprecipitation assay. Prevalence and look-back data will be presented, along with an evaluation of the relationship between transfusion and recipient infection.
  • Early Screening of Apheresis Platelets Reduces the Risk of Bacterially Contaminated Platelets—the PASSPORT Study. The purpose of the study was to test stored apheresis platelets for the presence of bacteria at 7 days (at outdate) and to compare the results with samples obtained 24 to 36 hours after collection. Reported septic episodes from stored platelets were also evaluated.

Abstracts at a Glance

Category

2008

2007

2006

2005

2004

2003

2002

2001

Submitted

 

 

 

 

 

 

 

 

 

Domestic

663

570

545

521

533

457

465

405

 

International

460

307

250

281

226

230

172

246

 

Total

1123

877

795

802

759

687

637

651

Accepted

 

 

 

 

 

 

 

 

 

Domestic

592

536

506

472

458

400

386

404

 

International

373

278

217

242

192

184

130

247

 

Total

965

814

723

714

650

584

516

531

Acceptance Rate (%)

 

 

 

 

 

 

 

 

 

Domestic

89

94

93

91

86

88

83

99

 

International

81

91

87

86

85

85

76

99

Scientific

 

 

 

 

 

 

 

 

 

Oral

150

114

105

102

108

142

100

150

 

Poster

590

512

398

424

382

302

309

294

 

Total

740

626

503

526

490

444

409

444

Administrative

 

 

 

 

 

 

 

 

 

Oral

34

24

24

24

12

8

9

6

 

Poster

191

158

189

158

152

132

90

74

 

Total

225

182

213

182

164

140

99

80


Note: For the purpose of comparison with other years, online-only abstracts in 2008 are included in the poster totals. Totals of scientific and administrative abstracts may not equal total accepted in some years because some presenters withdraw after acceptance.



Return to Main Menu
Last modified on 10/2/2008 10:00:03 AM
What's New!
AABB Weekly Report - March 5, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details